The Official Journal of the Turkish Society Of Clinical Microbiology and Infectious Diseases (KLİMİK)

Vaccination

Filter Newest Oldest Showing 1-17 of 17 results
Original Article / VOLUME 1, ISSUE 2, AUGUST 2019

The Knowledge, Attitudes and Beliefs of the Healthcare Workers about Influenza Infection and Vaccination at a Public Hospital in Turkey

Ezgi Gülten and others

Seasonal influenza is an important cause of mortality, particularly in immunocompromised and elderly patients, children, pregnant and postpartum women. Iuliano et al. estimated that each year 291,243 to 645,832 deaths are attributed to seasonal influenza. Turkey is located in the northern hemisphere; therefore, the majority of the influenza cases occur between October and [...] Read More

Commentary / VOLUME 3, ISSUE 1, APRIL 2021

The Impact of SARS-CoV-2 Variants on Morbidity, Mortality and Effectiveness of Vaccines

Kenan Midilli

Coronaviruses are known to evolve slower than the other RNA viruses; however, SARS-CoV-2 underwent a major shift through D614G change in February 2020, even before the declaration of a pandemic by WHO and D614G variant became rapidly dominant throughout the world.  The spike protein of this variant with D614G change have a higher affinity to […] Read More

Original Article / VOLUME 4, ISSUE 2, JUNE 2022

Nasopharyngeal Carriage and Serotype Distribution of Streptococcus pneumoniae in Elderly: A Cross-sectional Study in Turkey

Muammer Çelik and others

Invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae is an important cause of morbidity and mortality among young children and adults 65 years and older. S. pneumoniae is one of the most important causes of serious diseases, such as pneumonia, meningitis, and bacteremia. According to 2018 surveillance data from US Centers for Disease (...) Read More

Brief Report / VOLUME 4, ISSUE 2, JUNE 2022

SARS-CoV-2 IgG Antibody Levels After Inactivated Vaccine (CoronaVac) among Elderly

Harika Öykü Dinç and others

Despite the decrease in incidence after having widespread vaccination programs, the COVID-19 pandemic continues to cause high morbidity and mortality in the world in its second year. Especially elderly people (over 65 years old), people with underlying health conditions, and healthcare workers (HCWs) are still at high risk for COVID-19 disease. Since […] Read More

Case Report / VOLUME 4, ISSUE 3, SEPTEMBER 2022

Subacute and Recurrent Transient Perivascular Inflammation of the Carotid Artery (TIPIC syndrome) and Supraclavicular Lymphadenopathy Associated with Ipsilateral Intramuscular m-RNA COVID-19 Vaccine

Sıla Ulus and others

Transient perivascular inflammation of the carotid artery (TIPIC) syndrome is a rare disease. Recently, characteristic imaging findings were classified. The most common appearance is the existence of focal eccentric thickening of the carotid wall and abnormal soft tissue surrounding the carotid artery, especially near the bifurcation and usually without any (...) Read More

Original Article / VOLUME 5, ISSUE 2, JUNE 2023

Change in Rates of HBsAg and Anti-HBs in Şırnak 20 Years After Introduction of Hepatitis B Vaccine into Routine Infant Immunization Program

Meyha Şahin and Meltem Yazla

Chronic hepatitis B virus (HBV) infection is a serious public health problem affecting 257 million people worldwide (3.5% of the world population), according to World Health Statistics 2015 by the World Health Organization (WHO). In Turkey, approximately 3.3 million people (4.57% of the population) are considered HBsAg (hepatitis B surface antigen) positive (...) Read More

Original Article / VOLUME 5, ISSUE 2, JUNE 2023

The Impact of Vaccination Among Hospitalized Patients with the Diagnosis of COVID-19

Yeşim Yıldız and others

Vaccines to prevent SARS-CoV-2 infection are the most promising and effective approach to curb the COVID-19 pandemic, as well as to reduce hospitalizations and prevent mortality.  In our country, the CoronaVac (Sinovac Biotech, China) vaccine started to be administered as of January 13, 2021, and the Comirnaty (BNT162b2, Pfizer-BioNTech) vaccine as (...) Read More

Original Article / VOLUME 5, ISSUE 3, SEPTEMBER 2023

Long-Term Symptoms and Quality of Life in Persons with COVID-19

Nuriye Yalçın-Çolak and others

COVID-19, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is a zoonotic infection that emerged in Wuhan province of China in December 2019. SARS-COV-2 is a Betacoronavirus that is classified in Riboviria realm, Nidovirales order, and Coronaviridae family (1). Although the fatality rate of SARS-CoV-2 (2.6%) is lower than SARS-CoV (11%) and MERS-CoV (35-50%), it was much more severe worldwide (...) Read More

Original Article / VOLUME 5, ISSUE 4, DECEMBER 2023

Evaluation of Hospitalized Patients with Community-Acquired Influenza-Like Illness During Two Influenza Seasons

Özge Özgen-Top and others

Influenza-like illness (ILI) can be caused by a range of respiratory viruses in adults. Influenza is one of the most important respiratory viruses that affects all age groups and can lead to hospitalizations. Severe influenza and complications can cause significant morbidity and mortality during pandemics, epidemics, and sporadic outbreaks. Therefore, influenza (...) Read More

Original Article / VOLUME 6, ISSUE 2, JUNE 2024

The COVID-19 Vaccine Hesitancy Among Healthcare Workers: An Exploration of Hesitancy Reasons and Suggestions to Improve Vaccination Rates

Bahar Madran and others

The global impact of the coronavirus disease (COVID-19) pandemic has been profound, affecting billions of lives worldwide. As of June 13, 2024, the virus has infected approximately 704 million people and led to a staggering death toll of 7 million. In the fight against this devastating virus, the development and distribution of COVID-19 vaccines have been identified (...) Read More

Original Article / VOLUME 6, ISSUE 2, JUNE 2024

COVID-19 Vaccines and COVID-19 in People Living with HIV

Muhammed Fatih Karaşın and others

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a strain of the coronavirus that causes COVID-19, spread rapidly around the world and was defined as a pandemic on March 12, 2020, by the World Health Organization. As of June 2023, more than 767 million cases were confirmed globally, along with 6.9 million deaths. Read More